文献速递复苏、休克与脓毒症消化、代谢与肾脏急症重症综合管理与镇静镇痛

Nrf2/GPX4介导的铁死亡在脓毒症肠损伤中的作用

[Role of Nrf2/GPX4 mediated ferroptosis in intestinal injury in sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论脓毒症大鼠肠损伤存在铁死亡,经Nrf2/GPX4通路刺激或抑制铁死亡可干预炎症状态与肠道机械屏障。

该研究将48只雄性SD大鼠随机分为假手术组、脓毒症组(CLP)、脓毒症+去铁胺(DFO)组和脓毒症+Erastin组,每组12只,观察24小时生存率及肠组织铁死亡指标、炎症因子和肠屏障功能。结果显示CLP组和CLP+Erastin组24小时生存率显著低于假手术组(66.7%、50.0% vs. 100%,均P<0.05),CLP+DFO组与假手术组无显著差异(83.3% vs. 100%,P=0.25)。CLP组肠组织GPX4和Claudin-1表达下降、Nrf2表达升高,DFO可逆转上述改变,Erastin则进一步加剧。作者结论认为脓毒症肠损伤存在铁死亡,通过Nrf2/GPX4通路刺激或抑制铁死亡可有效干预机体炎症状态和肠道机械屏障。

要点

  • 脓毒症大鼠肠损伤存在铁死亡:CLP组肠组织GPX4/β-actin为0.56±0.02、Claudin-1/β-actin为0.60±0.04,均低于假手术组的1.57±0.01和1.40±0.01(均P<0.05)。
  • 铁螯合剂DFO可减轻脓毒症肠损伤:CLP+DFO组24小时生存率83.3%,与假手术组100%无显著差异(P=0.25),而CLP组为66.7%(P<0.05)。
  • 铁死亡诱导剂Erastin加重脓毒症肠损伤:CLP+Erastin组24小时生存率50.0%,低于假手术组100%(P<0.05),Chiu评分4.50±0.55高于CLP组3.25±0.46(P<0.05)。
  • DFO改善肠屏障与炎症:CLP+DFO组Claudin-1/β-actin为0.96±0.07,高于CLP组0.60±0.04;血清IL-6为45.90±6.52 ng/L,低于CLP组112.50±9.76 ng/L(均P<0.05)。
  • Nrf2/GPX4通路参与调控:CLP+DFO组Nrf2/β-actin为0.72±0.01,低于CLP组0.88±0.02;CLP+Erastin组Nrf2/β-actin为1.14±0.01,高于CLP组(均P<0.05)。

适用人群与场景

  • SPF级雄性Sprague-Dawley(SD)大鼠,体重220-250 g,共48只,随机分为假手术组、脓毒症组(CLP组)、脓毒症+去铁胺组(CLP+DFO组)和脓毒症+Erastin组(CLP+Erastin组),每组12只。
  • 脓毒症模型采用盲肠结扎穿刺(CLP)建立;假手术组仅行开腹和关腹操作。

处置流程与药物剂量

  • CLP+DFO组在建模后皮下注射20 mg/kg去铁胺(DFO)。
  • CLP+Erastin组在建模后腹腔注射20 mg/kg Erastin。
  • 各组术后均皮下注射50 mg/kg生理盐水进行液体复苏,术后观察24小时生存状态。
  • 建模后24小时,每组取6只大鼠取活体小肠组织观察平滑肌细胞线粒体形态并测定活性氧(ROS),随后腹主动脉采血后处死;剩余6只大鼠完成腹主动脉采血后处死,取小肠组织。
  • 采用Western blotting检测肠损伤标志物Claudin-1及铁死亡相关蛋白GPX4和Nrf2表达;HE染色观察小肠组织病理改变并完成Chiu评分;ELISA检测血清肿瘤坏死因子-α(TNF-α)、白细胞介素(IL-1β、IL-6)水平;检测血清铁离子(Fe3+)、丙二醛(MDA)和D-乳酸脱氢酶(D-LDH)水平。

研究设计与关键结果

  • 研究类型:动物实验;样本量:48只SD大鼠,每组12只。
  • 24小时生存率:CLP组66.7%、CLP+Erastin组50.0%,均显著低于假手术组100%(均P<0.05);CLP+DFO组83.3%与假手术组100%无显著差异(P=0.25)。
  • Western blotting:与假手术组相比,CLP组、CLP+DFO组和CLP+Erastin组小肠组织GPX4和Claudin-1表达显著降低,Nrf2表达显著升高(GPX4/β-actin:0.56±0.02、1.03±0.01、0.32±0.01 vs. 1.57±0.01;Claudin-1/β-actin:0.60±0.04、0.96±0.07、0.41±0.01 vs. 1.40±0.01;Nrf2/β-actin:0.88±0.02、0.72±0.01、1.14±0.01 vs. 0.43±0.02,均P<0.05);与CLP组相比,CLP+DFO组GPX4和Claudin-1表达显著升高、Nrf2表达显著降低,CLP+Erastin组GPX4和Claudin-1表达进一步降低、Nrf2表达进一步升高(均P<0.05)。
  • 光镜下CLP组、CLP+DFO组和CLP+Erastin组小肠黏膜和黏膜下组织结构紊乱、炎症细胞浸润明显、腺体和绒毛结构破坏,Chiu评分显著高于假手术组(3.25±0.46、2.00±0.82、4.50±0.55 vs. 1.25±0.45,均P<0.05)。
  • 透射电镜下CLP组、CLP+DFO组和CLP+Erastin组小肠平滑肌细胞线粒体呈不同程度体积缩小、膜密度增加、嵴减少或消失,CLP+Erastin组变化最显著,CLP+DFO组线粒体形态仅轻度改变。
  • 与假手术组相比,CLP组、CLP+DFO组和CLP+Erastin组血清TNF-α、IL-1β、IL-6、MDA、D-LDH及小肠组织ROS水平显著升高,血清Fe3+含量显著降低(TNF-α(ng/L):21.49±1.41、17.24±1.00、28.66±2.72 vs. 14.17±1.24;IL-1β(ng/L):108.40±3.09、43.19±8.75、145.70±11.00 vs. 24.50±5.55;IL-6(ng/L):112.50±9.76、45.90±6.52、151.80±9.38 vs. 12.89±6.11;MDA(μmol/L):5.61±0.49、3.89±0.28、8.56±1.17 vs. 1.86±0.41;D-LDH(kU/L):39.39±3.22、25.38±2.34、53.29±10.53 vs. 10.79±0.52;

证据类型、等级与局限

  • 证据类型:动物实验(大鼠CLP脓毒症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该动物实验提示脓毒症肠损伤存在铁死亡,通过Nrf2/GPX4通路刺激或抑制铁死亡可有效干预机体炎症状态和肠道机械屏障(作者结论)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate whether ferroptosis exists in sepsis induced intestinal injury, and to verify the association between ferroptosis in sepsis induced intestinal injury and intestinal inflammation and barrier function by stimulating and inhibiting the nuclear factor E2-related factor 2/glutathione peroxidase 4 (Nrf2/GPX4) pathway.

METHODS: Forty-eight SPF grade male Sprague-Darvley (SD) rats with a body weight of 220-250 g were divided into sham operation group (Sham group), sepsis group (CLP group), sepsis+iron chelating agent deferoxamine (DFO) group (CLP+DFO group) and sepsis+ferroptosis inducer Erastin group (CLP+Erastin group) using a random number table method, with 12 rats in each group. The sepsis model was established by cecal ligation and puncture (CLP). The Sham group was only performed with abdominal opening and closing operations. After modeling, the CLP+DFO group received subcutaneous injection of 20 mg/kg of DFO, the CLP+Erastin group was intraperitoneally injected with 20 mg/kg of Erastin. Each group received subcutaneous injection of 50 mg/kg physiological saline for fluid resuscitation after surgery, and the survival status of the rats was observed 24 hours after surgery. At 24 hours after model establishment, 6 rats in each group were selected. First, live small intestine tissue was taken for observation of mitochondrial morphology in smooth muscle cells under transmission electron microscopy and determination of reactive oxygen species (ROS). Then, blood was collected from the abdominal aorta and euthanized. The remaining 6 rats were sacrificed after completing blood collection from the abdominal aorta, and then small intestine tissue was taken. Western blotting was used to detect the expression of intestinal injury markers such as Claudin-1 and ferroptosis related proteins GPX4 and Nrf2. Observe the pathological changes of small intestine tissue using hematoxylin-eosin (HE) staining and complete Chiu score; Detection of tumor necrosis factor-α (TNF-α), interleukins (IL-1β, IL-6) levels in serum using enzyme-linked immunosorbent assay (ELISA). The levels of serum iron ions (Fe3+), malondialdehyde (MDA), and D-lactate dehydrogenase (D-LDH) were measured.

RESULTS: (1) Compared with the Sham group, the 24-hour survival rate of rats in the CLP group and CLP+Erastin group significantly decreased (66.7%, 50.0% vs. 100%, both P < 0.05), while there was no significant difference in the CLP+DFO group (83.3% vs. 100%, P = 0.25). (2) Western blotting results showed that compared with the Sham group, the expressions of GPX4 and Claudin-1 in the small intestine tissue of the CLP group, CLP+DFO group, and CLP+Erastin group decreased significantly, while the expression of Nrf2 increased significantly (GPX4/β-actin: 0.56±0.02, 1.03±0.01, 0.32±0.01 vs. 1.57±0.01, Claudin-1/β-actin: 0.60±0.04, 0.96±0.07, 0.41±0.01 vs. 1.40±0.01, Nrf2/β-actin: 0.88±0.02, 0.72±0.01, 1.14±0.01 vs. 0.43±0.02, all P < 0.05). Compared with the CLP group, the expressions of GPX4 and Claudin-1 were significantly increased in the CLP+DFO group, while the expression of Nrf2 was significantly reduced. In the CLP+Erastin group, the expressions of GPX4 and Claudin-1 further decreased, while the expression of Nrf2 further increased (all P < 0.05). (3) Under the light microscope, compared with the Sham group, the CLP group, CLP+DFO group, and CLP+Erastin group showed structural disorder in the small intestinal mucosa and submucosal tissue, significant infiltration of inflammatory cells, and destruction of glandular and villous structures. The Chui score was significantly higher (3.25±0.46, 2.00±0.82, 4.50±0.55 vs. 1.25±0.45, all P < 0.05). (4) Under transmission electron microscopy, compared with the Sham group, the mitochondria in the other three groups of small intestinal smooth muscle cells showed varying degrees of volume reduction, increased membrane density, and reduced or disappeared cristae. The CLP+Erastin group showed the most significant changes, while the CLP+DFO group showed only slight changes in mitochondrial morphology. (5) Compared to the Sham group, the CLP group, CLP+DFO group, and CLP+Erastin group had serum levels of TNF-α, IL-1β, IL-6, MDA, D-LDH, and ROS in small intestine tissue were significantly increased, while the serum Fe3+ content was significantly reduced [TNF-α (ng/L): 21.49±1.41, 17.24±1.00, 28.66±2.72 vs. 14.17±1.24; IL-1β (ng/L): 108.40±3.09, 43.19±8.75, 145.70±11.00 vs. 24.50±5.55; IL-6 (ng/L): 112.50±9.76, 45.90±6.52, 151.80±9.38 vs. 12.89±6.11; MDA (μmol/L): 5.61±0.49, 3.89±0.28, 8.56±1.17 vs. 1.86±0.41; D-LDH (kU/L): 39.39±3.22, 25.38±2.34, 53.29±10.53 vs. 10.79±0.52; ROS (fluorescence intensity): 90 712±6 436, 73 278±4 775, 110 913±9 287 vs. 54 318±2 226; Fe3+ (μmol/L): 22.19±1.34, 34.05±1.94, 12.99±1.08 vs. 51.74±11.07; all P < 0.05]. Compared with CLP group, the levels of TNF-α, IL-1β, IL-6, MDA, D-LDH and ROS in CLP+Erastin group were further increased, and the content of Fe3+ was further decreased, the CLP+DFO group was the opposite (all P < 0.05).

CONCLUSIONS: Ferroptosis exists in the intestinal injury of septic rats, and stimulating or inhibiting ferroptosis through the Nrf2/GPX4 pathway can effectively intervene in the inflammatory state and intestinal mechanical barrier of the body.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Ma T, Huang W, Li Z, et al. [Role of Nrf2/GPX4 mediated ferroptosis in intestinal injury in sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37987130. doi:10.3760/cma.j.cn121430-20230616-00451

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。